NCT00950586View on ClinicalTrials.gov

Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

August 24, 2009

Primary Completion Date

December 24, 2009

Study Completion Date

December 24, 2009

Conditions

Cognitive Disorders

Interventions

DRUG

GSK1043702

Oral dose in liquid or tablet formulation

DRUG

Dextromethorphan

30mg Oral dose

DRUG

Placebo

To match GSK1034702

Trial Locations (1)

NW10 7EW

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY